Filing Details

Accession Number:
0001209191-15-028519
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-23 16:05:41
Reporting Period:
2015-03-20
Filing Date:
2015-03-23
Accepted Time:
2015-03-23 16:05:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
31791 Perkinelmer Inc PKI Laboratory Analytical Instruments (3826) 042052042
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1359052 James Corbett 940 Winter Street
Waltham MA 02451
Please See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-20 2,087 $26.15 28,502 No 4 M Direct
Common Stock Acquisiton 2015-03-20 1,319 $33.87 29,821 No 4 M Direct
Common Stock Disposition 2015-03-20 5,157 $50.23 24,664 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock NQ Stock Option (right to buy) Disposition 2015-03-20 2,087 $0.00 2,087 $26.15
Common Stock NQ Stock Option (right to buy) Disposition 2015-03-20 1,319 $0.00 1,319 $33.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,175 2019-02-07 No 4 M Direct
9,232 2020-02-05 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Corbett on February 18, 2015.
  2. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $49.970 to $50.270. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  3. This option became exercisable in three equal annual installments beginning on February 7, 2013, which was the first anniversary of the date on which the option was granted.
  4. This option became exercisable in three equal annual installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted.